ANDA 207049, held by Epic Pharma. Voriconazole.
As of Nov 21, 2026, ANDA 207049 (Voriconazole), held by Epic Pharma, was first approved by FDA on Sep 7, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 7, 2016 | Original application | Approved | None posted |
| Voriconazole50MG · tablet;oral | Voriconazole | Rx |
| Voriconazole200MG · tablet;oral | Voriconazole | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters